A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF
Clinical trial NCT01326962 · COMPLETED
Trial details
- NCT number
- NCT01326962
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-30
- Primary completion
- 2013-05-12
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.